版本:
中国

BRIEF-Aviragen Therapeutics announces review of strategic alternatives

April 4 Aviragen Therapeutics Inc

* Company has retained Stifel, Nicolaus & Company, incorporated to serve as its financial advisor in process

* Aviragen therapeutics announces review of strategic alternatives and provides corporate update

* Does not have a defined timeline for exploration of strategic alternatives

* To explore strategic alternatives that include business combination or merger, in-licensing clinical stage programs, deal or other transaction

* Aviragen is not confirming that process will result in any strategic alternative being announced or consummated Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐